144 related articles for article (PubMed ID: 15869797)
1. Probing the potential of platinum(II) complexes for the inhibition of thiol-dependent enzymatic activity.
van Zutphen S; Kraus M; Driessen C; van der Marel GA; Overkleeft HS; Reedijk J
J Inorg Biochem; 2005 Jun; 99(6):1384-9. PubMed ID: 15869797
[TBL] [Abstract][Full Text] [Related]
2. Rhenium inhibitors of cathepsin B (ReO(SYS)X (where Y = S, py; X = Cl, Br, SPhOMe-p)): Synthesis and mechanism of inhibition.
Mosi R; Baird IR; Cox J; Anastassov V; Cameron B; Skerlj RT; Fricker SP
J Med Chem; 2006 Aug; 49(17):5262-72. PubMed ID: 16913715
[TBL] [Abstract][Full Text] [Related]
3. Tellurium-based cysteine protease inhibitors: evaluation of novel organotellurium(IV) compounds as inhibitors of human cathepsin B.
Cunha RL; Urano ME; Chagas JR; Almeida PC; Bincoletto C; Tersariol IL; Comasseto JV
Bioorg Med Chem Lett; 2005 Feb; 15(3):755-60. PubMed ID: 15664852
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of lysosomal cysteine proteases by a series of Au(I) complexes: a detailed mechanistic investigation.
Gunatilleke SS; Barrios AM
J Med Chem; 2006 Jun; 49(13):3933-7. PubMed ID: 16789749
[TBL] [Abstract][Full Text] [Related]
5. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of cysteine proteases.
Govardhan CP; Abeles RH
Arch Biochem Biophys; 1996 Jun; 330(1):110-4. PubMed ID: 8651683
[TBL] [Abstract][Full Text] [Related]
7. Syntheses and SH-enzyme inhibitory activities of new epoxysuccinic acid piperazine derivatives against mu-calpain and cathepsin B.
Inoue J; Yoshida Y; Nakamura M; Cui YS; Nagao Y
Drug Des Discov; 1999 Aug; 16(2):165-9. PubMed ID: 10533812
[TBL] [Abstract][Full Text] [Related]
8. Novel functions of human alpha(1)-protease inhibitor after S-nitrosylation: inhibition of cysteine protease and antibacterial activity.
Miyamoto Y; Akaike T; Alam MS; Inoue K; Hamamoto T; Ikebe N; Yoshitake J; Okamoto T; Maeda H
Biochem Biophys Res Commun; 2000 Jan; 267(3):918-23. PubMed ID: 10673391
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitubercular activity of palladium and platinum complexes with fluoroquinolones.
Vieira LM; de Almeida MV; Lourenço MC; Bezerra FA; Fontes AP
Eur J Med Chem; 2009 Oct; 44(10):4107-11. PubMed ID: 19482387
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the cathepsin cysteine proteases B and K by square-planar cycloaurated gold(III) compounds and investigation of their anti-cancer activity.
Zhu Y; Cameron BR; Mosi R; Anastassov V; Cox J; Qin L; Santucci Z; Metz M; Skerlj RT; Fricker SP
J Inorg Biochem; 2011 May; 105(5):754-62. PubMed ID: 21481817
[TBL] [Abstract][Full Text] [Related]
11. Terpyridine platinum(II) complexes inhibit cysteine proteases by binding to active-site cysteine.
Lo YC; Su WC; Ko TP; Wang NC; Wang AH
J Biomol Struct Dyn; 2011 Oct; 29(2):267-82. PubMed ID: 21875148
[TBL] [Abstract][Full Text] [Related]
12. The 1,4-naphthoquinone scaffold in the design of cysteine protease inhibitors.
Valente C; Moreira R; Guedes RC; Iley J; Jaffar M; Douglas KT
Bioorg Med Chem; 2007 Aug; 15(15):5340-50. PubMed ID: 17532221
[TBL] [Abstract][Full Text] [Related]
13. Platinum (II) complexes with stereochemically-defined thiepane dioxide diamine ligands as anticancer drugs.
Cerè V; Grossi L; Munari D; Pollicino S; Martelli L; Martelli M
Anticancer Res; 2006; 26(3A):1815-9. PubMed ID: 16827112
[TBL] [Abstract][Full Text] [Related]
14. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
Roy S; Westmaas JA; Buda F; Reedijk J
J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
[TBL] [Abstract][Full Text] [Related]
15. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, DNA interaction and cytotoxicity studies of cis-{[1, 2-bis(aminomethyl)cyclohexane]dihalo}platinum(II) complexes.
de Mier-Vinué J; Lorenzo J; Montaña AM; Moreno V; Avilés FX
J Inorg Biochem; 2008 Apr; 102(4):973-87. PubMed ID: 18267344
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization, antibacterial and cytotoxic study of platinum (IV) complexes.
Mishra AK; Mishra SB; Manav N; Saluja D; Chandra R; Kaushik NK
Bioorg Med Chem; 2006 Sep; 14(18):6333-40. PubMed ID: 16765599
[TBL] [Abstract][Full Text] [Related]
18. Discovery and kinetic evaluation of 6-substituted 4-benzylthio-1,3,5-triazin-2(1H)-ones as inhibitors of cathepsin B.
Sosič I; Mirković B; Turk S; Štefaneb B; Kos J; Gobec S
Eur J Med Chem; 2011 Sep; 46(9):4648-56. PubMed ID: 21849222
[TBL] [Abstract][Full Text] [Related]
19. Metal compounds for the treatment of parasitic diseases.
Fricker SP; Mosi RM; Cameron BR; Baird I; Zhu Y; Anastassov V; Cox J; Doyle PS; Hansell E; Lau G; Langille J; Olsen M; Qin L; Skerlj R; Wong RS; Santucci Z; McKerrow JH
J Inorg Biochem; 2008 Oct; 102(10):1839-45. PubMed ID: 18684510
[TBL] [Abstract][Full Text] [Related]
20. Platinum (IV) thiohydrazide, thiodiamine and thiohydrazone complexes: a spectral, antibacterial and cytotoxic study.
Mishra AK; Mishra SB; Manav N; Kumar R; Sharad ; Chandra R; Saluja D; Kaushik NK
Spectrochim Acta A Mol Biomol Spectrosc; 2007 Apr; 66(4-5):1042-7. PubMed ID: 16920010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
